Daewoong Pharmaceutical's botulinum toxin product, 'Nabota,' recorded sales of 115.4 billion won on the 31st in the first half of the year. This represents an approximate 28% increase compared to the same period last year. Daewoong Pharmaceutical's botulinum toxin received approval from the U.S. Food and Drug Administration (FDA) in 2019, becoming the first in Asia to do so. Nabota has a 14% market share in the U.S. under the brand name 'Juvo.' Previously, contracts for export worth 180 billion won were signed in Brazil and 73.8 billion won in Thailand. Recently, an export contract was also signed with Kuwait.
Celltrion announced on the 31st that it has demonstrated the efficacy and safety of 'Vegzelma' in a long-term global Phase 3 clinical study. Vegzelma is a biosimilar of the anticancer drug Avastin (ingredient name: Bevacizumab). The company noted that it has comprehensively proven the long-term treatment effects and intends to expand its market share in major countries around the world.
Ildong Pharmaceutical announced on the 31st that it has introduced a liquid digestive aid called 'Ildong Pyeonsok Liquid.' It helps with indigestion, heartburn, abdominal pain, gastric pain, overeating, vomiting, diarrhea, and loss of appetite. It contains digestive aids, pain relievers, and anti-diarrheal agents. No preservatives or colorings are added, and it includes the natural substance fructooligosaccharide.
RP Bio announced on the 31st that its natural ingredient 'sunflower seed extract' has received individual recognition from the Ministry of Food and Drug Safety. The sunflower seed extract contains chlorogenic acid, which aids in reducing body fat. The company aims to introduce diet products utilizing the extract in the first half of next year.
Pharmgen Science announced on the 31st that it has donated pharmaceuticals worth 200 million won to the Korea Love Sharing Community, a non-profit organization. The donation includes COVID-19 self-test kits and treatment adhesive patches for chronic bronchitis and asthma. The pharmaceuticals will be delivered to domestic welfare facilities, vulnerable medical groups, and the Ukrainian Veterans Association.
JW Pharmaceutical announced on the 31st that it will pre-sell the 2025-2026 flu vaccine on its 'JWP Mall' platform. The vaccine's price and quantity will be confirmed to ensure stable supply to hospitals and clinics. JWP Mall is a B2B platform for pharmaceuticals aimed at medical institutions.
CG MedTech announced on the 31st that it has acquired dental parts manufacturing company 'Dental Ocean.' With this acquisition, the company has laid the foundation to manufacture core components for dental implants in-house. Dental Ocean possesses capabilities in developing, manufacturing, and post-processing of the substructure 'fixture.'